Latest news for Aspen Pharmacare Holdings Ltd. (JSE:APN)

LATEST NEWS FOR Aspen Pharmacare Holdings Ltd.

Aspen is a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable medicines. Active at every stage of the value chain, we are uniquely diversified by geography, p... [more info]

Click this company SENS Announcements

Viewing 1 - 15 of 175 total

1 2 3 … 12 Next

NHI: Where are we today?

29 Mar 2021 / Kwaku Koranteng 22

The financial resources remain a concern.

Aspen Pharmacare rapporteer ‘n half-jaar winsdaling van 18%

12 Mar 2021 / Moneyweb

Gus Attridge – adjunk-hoof, Aspen Pharmacare

Aspen Pharmacare reports 18% drop in half-year profit

12 Mar 2021 / Promit Mukherjee, Reuters

Profit from continuing operations up 11%.

Opportunity in the S&P500 value index

18 Feb 2021 / Simon Brown

Gary Booysen from Rand Swiss on the Dis-Chem update and healthcare stocks. 10X Investment's Michael Rossouw talks the real impact and costs of early retirement withdrawals. Investec’s Brian McMillan on their new SP500 structured product.

Growthpoint’s La Lucia Mall to get R142m apartment development

17 Feb 2021 / Suren Naidoo 3

Marking the group’s first residential property foray in KwaZulu-Natal.

Bullish markets and the rand set for further gains

15 Feb 2021 / Simon Brown 1

Petri Redelinghuys from Herenya Capital on the top 40 trend looking up and Aspen on its channel range, Anchor Capital's Nolan Wapenaar talks markets as the rand powers stronger. FNB's Chantal Robertson on tax loop structures and relaxed regulations.

Aspen to dodge EU antitrust fine with cancer drug price cut offer -sources

3 Feb 2021 / Foo Yun Chee and Promit Mukherjee, Reuters

The price cuts will cover all of Europe except for Italy.

J&J plans to submit South African vaccine trial data

13 Jan 2021 /

US drug giant is one of four vaccine developers running late-stage trials in SA.

J&J plans to submit SA vaccine trial data by Jan 21

11 Jan 2021 / Antony Sguazzin, Bloomberg

If approved, Aspen Pharmacare will manufacture 300m doses a year in South Africa.

[TOP STORY] A strong start to the year

11 Jan 2021 / Simon Brown 1

Nick Kunze of Sanlam Private Wealth looks at the JSE overall, Sasol and Aspen.

Sasol and Aspen lead a great start to markets in 2021

11 Jan 2021 / Simon Brown

Sanlam's Nick Kunze on a storming start to the JSE in 2021, what’s driving it? Mike Gresty, Anchor Capital CIO, on their top local stock picks for the year.

SA stocks at fresh record

UPDATE

8 Jan 2021 / John Viljoen, Bloomberg 6

In best start to year since 1999.

Aspen could produce J&J COVID shots by end-March

Viewing 1 - 15 of 175 total

1 2 3 … 12 Next

MORE DATA TOOLS

ALL DATA TOOLS

SEARCH ARTICLES BY COMPANY
Enter company name or share code:

SEARCH COMPANIES
Enter company name or share code:

MENU